Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

ACADL Gene LCAD Deficiency NGS Genetic Test | DNA Labs UAE

Executive Summary & Core Metrics

This advanced next-generation sequencing (NGS) assay analyzes the ACADL gene to detect pathogenic variants associated with Long-Chain Acyl-CoA Dehydrogenase (LCAD) deficiency. Performed at our ISO 9001:2015 certified laboratory in Dubai Healthcare City, the test delivers >99.5% analytical sensitivity for single nucleotide variants (SNVs), indels, and copy number variations (CNVs). Our integrated service includes mandatory pre-test genetic counseling, VIP mobile phlebotomy with temperature-controlled cold-chain transport (daily 8 AM to 11 PM), and comprehensive post-test telemedicine consultation with a DHA-licensed Consultant Medical Geneticist.

99.9% Diagnostic Sensitivity – ISO 9001:2015 Certified Lab
VIP Mobile Phlebotomy & Cold-Chain Home Collection 8 AM–11 PM
Post-Test Genetic Counseling via Telemedicine
Direct Insurance Billing – WhatsApp +971 54 548 8731

Test Overview & Methodology

The ACADL Gene LCAD Deficiency NGS Test is a next-generation sequencing assay that screens the entire coding region of the ACADL gene for pathogenic variants linked to Long-Chain Acyl-CoA Dehydrogenase (LCAD) deficiency – a rare autosomal recessive inborn error of mitochondrial fatty acid oxidation. This advanced test is essential for confirming clinical suspicion, carrier testing, family screening, and guiding dietary management under UAE healthcare regulations.

FeatureOur NGS Test (UAE)Standard Single-Gene Sequencing
MethodologyNGS with full exon coverage & copy number variant (CNV) analysisSanger sequencing (may miss large deletions/duplications)
Turnaround Time3–4 weeks (expedited reporting available)4–6 weeks
Detection Rate>99.5% analytical sensitivity for SNVs, indels, and CNVs in ACADL~95% (misses copy number changes)
Pre-Test SupportMandatory genetic counselling & pedigree charting (included)Often not provided

Physician Insight & Safety Protocols

“As a DHA-licensed Consultant Medical Genetics, I underscore that the identification of a pathogenic or likely pathogenic variant in the ACADL gene is not a standalone diagnosis. Clinical correlation with plasma acylcarnitine profiles, urine organic acids, and fasting tolerance tests is mandatory. Do not interpret these results in isolation. A negative result does not entirely rule out a fatty acid oxidation disorder, as non-coding or large structural rearrangements may occasionally evade detection by standard NGS platforms. Patients should undergo detailed dietary and metabolic specialist evaluation prior to initiating any therapeutic intervention.”

— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403

⚠ Medical Advisory

Do not discontinue prescribed medications, metabolic formulas, or dietary modifications based solely on a preliminary genetic report. All treatment adjustments must be supervised by a metabolic specialist.

Exclusion Criteria & Emergency Red Flags

  • Testing is contraindicated for individuals currently experiencing acute metabolic decompensation, severe hypoglycemia, or hepatic dysfunction.
  • Informed consent must be obtained from a legal guardian for minors.
  • Emergency Red Flags: If you or a family member exhibit unexplained seizures, lethargy, vomiting, or respiratory distress during illness, seek emergency medical care immediately. Do not delay treatment to wait for genetic test results.

Patient FAQ & Clinical Guidance

1. What does a positive ACADL gene variant mean for my health?

A positive result indicates the presence of one or two pathogenic mutations in the ACADL gene. If two mutations are found (homozygous or compound heterozygous), it confirms a diagnosis of LCAD deficiency, a disorder impairing the breakdown of long-chain fatty acids. This condition is manageable through dietary intervention—such as medium-chain triglyceride supplementation and avoidance of fasting—alongside cardiorespiratory monitoring. Carrier status (one mutation) poses minimal health risk but has implications for family planning and should prompt cascade screening of relatives.

2. How is the sample collected, and is a home service available in the UAE?

A standard peripheral blood sample (3–5 mL in EDTA) is required. DNA Labs UAE offers a VIP mobile phlebotomy service across Dubai, Abu Dhabi, and the Northern Emirates, operating daily from 8 AM to 11 PM. Samples are transported under strict temperature-controlled cold-chain conditions to our facility in Dubai Healthcare City to ensure genomic integrity.

3. Will my insurance cover the cost of the ACADL LCAD deficiency genetic test?

Coverage depends on your specific UAE health insurance policy and the medical necessity criteria established by the DHA or HAAD. Many comprehensive plans cover genetic testing when ordered by a specialist. We recommend contacting our billing team via WhatsApp at +971 54 548 8731 with your policy details for a complimentary verification of benefits and pre-authorization assistance.

UAE Regulatory & Data Privacy Adherence

  • All personal genetic data is processed and stored in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
  • Our laboratory operations adhere to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
  • Patient consent and medical liability protocols are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
  • Laboratory supervised by Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA ID: 9294403).
  • Corporate Lab Branding: DNA Labs UAE. DHA Facility License Number: 1143.

Clinical & Logistical Metadata

ParameterSpecification
Test Name ACADL Gene LCAD Deficiency NGS Test
Price (AED) 2,800 AED
Turnaround Time 3–4 Weeks
Sample Type / Matrix Peripheral Whole Blood (EDTA) or Dried Blood Spot (DBS)
Methodology Used Next-Generation Sequencing (NGS) – Full Exon Coverage with CNV Analysis
ICD-10-CM Code E71.39
LOINC Code 21661-2
DHA Facility License & Address Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – License No. 1143

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians